Position in TCMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,596,505
+$883,967 QoQ
Shares Held
53,610
+96.6% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 179 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in TCMD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Man Group plc holds $533,295,768 across 39 Medical Devices names. TCMD ranks #19 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,225,164 | $137,649,998 | |
| 2 | EW |
Edwards Lifesciences Corp
|
935,186 | $84,596,924 | |
| 3 | PODD |
Insulet Corp
|
517,217 | $78,746,287 | |
| 4 | ABT |
Abbott Laboratories
|
800,719 | $72,657,242 | |
| 5 | MDT |
Medtronic plc
|
416,155 | $32,555,805 | |
| 6 | DXCM |
Dexcom Inc
|
394,449 | $26,566,138 | |
| 7 | PEN |
Penumbra Inc
|
80,224 | $25,330,727 | |
| 8 | STE |
STERIS plc
|
99,334 | $20,916,760 |
All Filings in TCMD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,596,505 | 53,610 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $712,538 | 27,269 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $412,459 | 29,802 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $288,503 | 28,452 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $436,141 | 32,991 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $578,600 | 33,777 | Shares | Defined | 2025-02-14 | |
| 2024-03-31 | $314,340 | 19,344 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $195,337 | 13,903 | Principal | Defined | 2023-11-14 | |
| 2022-12-31 | $121,286 | 10,565 | Shares | Defined | 2023-02-14 | |
| 2020-06-30 | $413,387 | 9,978 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||